Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation

Etifoxine, an 18 kDa translocator protein (TSPO) agonist for the treatment of anxiety disorders in clinic, may be able to cause acute liver injury or cytolytic hepatitis. TSPO has been demonstrated to participate in inflammatory responses in infective diseases as well as to modulate glucose and lipi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Lin, Yu-Min, Sun, Hung-Yu, Chiu, Wen-Tai, Su, Hui-Chen, Chien, Yu-Chieh, Chang, Heng-Ai, Chong, Lee-Won, Chang, Hung-Chuen, Young, Kung-Chia, Bai, Chyi-Huey, Tsao, Chiung-Wen
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6432734/
https://ncbi.nlm.nih.gov/pubmed/30984779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3102414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados